The one AIM pharma share that is starting to prove itself. Not by RNS's full of waffle, but by partnerships with leading health care providers. Shame it has fallen so much though.
It will come back down. You can bet on it. Its already back to 4p. It was 4.40p earlier, so there are already people 10% in a loss, and they will not hold.
Bearded. Being spiked means buying in first thing after an RNS lands when the share price is up 30%, only for it to come crashing back down to where it was before. Happens 90% of the time on AIM.